CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade Organovo Holdings, Inc. - ONVO CFD

    2.17
    2.84%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.024874%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		0.002651%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 20%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 2.11
    Open* 2.14
    1-Year Change* -43.09%
    Day's Range* 2.13 - 2.21
    52 wk Range 1.37-3.79
    Average Volume (10 days) 34.56K
    Average Volume (3 months) 2.52M
    Market Cap 19.08M
    P/E Ratio -100.00K
    Shares Outstanding 8.71M
    Revenue 1.71M
    EPS -1.34
    Dividend (Yield %) N/A
    Beta 0.88
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 31, 2023 2.17 0.04 1.88% 2.13 2.21 2.13
    Mar 30, 2023 2.11 -0.11 -4.95% 2.22 2.26 2.01
    Mar 29, 2023 2.24 0.12 5.66% 2.12 2.24 2.04
    Mar 28, 2023 2.17 -0.07 -3.13% 2.24 2.30 2.12
    Mar 27, 2023 2.22 0.19 9.36% 2.03 2.27 2.00
    Mar 24, 2023 1.98 0.07 3.66% 1.91 1.98 1.91
    Mar 23, 2023 1.93 -0.10 -4.93% 2.03 2.06 1.91
    Mar 22, 2023 1.99 0.06 3.11% 1.93 2.03 1.91
    Mar 21, 2023 1.91 0.03 1.60% 1.88 1.96 1.88
    Mar 20, 2023 1.88 -0.08 -4.08% 1.96 1.97 1.84
    Mar 17, 2023 1.93 0.04 2.12% 1.89 1.97 1.88
    Mar 16, 2023 1.94 0.05 2.65% 1.89 1.98 1.88
    Mar 15, 2023 1.89 0.01 0.53% 1.88 1.93 1.87
    Mar 14, 2023 1.94 0.05 2.65% 1.89 1.99 1.85
    Mar 13, 2023 1.87 0.14 8.09% 1.73 1.94 1.71
    Mar 10, 2023 1.78 -0.08 -4.30% 1.86 1.86 1.74
    Mar 9, 2023 1.85 -0.18 -8.87% 2.03 2.04 1.83
    Mar 8, 2023 2.05 -0.07 -3.30% 2.12 2.12 2.02
    Mar 7, 2023 2.10 -0.08 -3.67% 2.18 2.19 2.03
    Mar 6, 2023 2.21 0.03 1.38% 2.18 2.23 2.17

    Organovo Holdings, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1.5 0 2.196 3.091 4.603
    Revenue 1.5 0 2.196 3.091 4.603
    Cost of Revenue, Total 0 0.328 0.482 1.03
    Gross Profit 0 1.868 2.609 3.573
    Total Operating Expense 12.979 16.826 23.671 30.365 39.874
    Selling/General/Admin. Expenses, Total 9.631 12.9 14.423 15.131 20.888
    Research & Development 3.206 1.077 5.051 14.752 17.956
    Operating Income -11.479 -16.826 -21.475 -27.274 -35.271
    Interest Income (Expense), Net Non-Operating 0.008 0.015 0.594 0.705 0.478
    Gain (Loss) on Sale of Assets 0 -0.019 0.113 -0.063 0.004
    Net Income Before Taxes -11.446 -16.824 -18.708 -26.632 -34.801
    Net Income After Taxes -11.448 -16.826 -18.71 -26.635 -34.803
    Net Income Before Extra. Items -11.448 -16.826 -18.71 -26.635 -34.803
    Net Income -11.448 -16.826 -18.71 -26.635 -34.803
    Income Available to Common Excl. Extra. Items -11.448 -16.826 -18.71 -26.635 -34.803
    Income Available to Common Incl. Extra. Items -11.448 -16.826 -18.71 -26.635 -34.803
    Diluted Net Income -11.448 -16.826 -18.71 -26.635 -34.803
    Diluted Weighted Average Shares 8.7036 6.902 6.47781 5.769 5.3622
    Diluted EPS Excluding Extraordinary Items -1.31532 -2.43784 -2.88832 -4.61692 -6.49043
    Diluted Normalized EPS -1.31532 -2.17161 -2.62603 -4.60982 -6.49092
    Other, Net 0.025 0.006 2.06 0 -0.012
    Total Extraordinary Items 0
    Depreciation / Amortization 0.142 0.041 1.142
    Unusual Expense (Income) 0 2.808 2.727
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 0.131 0.077 0 1.5 0
    Revenue 0.131 0.077 1.5
    Cost of Revenue, Total
    Gross Profit
    Total Operating Expense 3.49 3.431 3.239 3.413 3.5
    Selling/General/Admin. Expenses, Total 2.22 2.185 2.205 2.265 2.569
    Research & Development 1.14 1.191 0.984 1.102 0.894
    Depreciation / Amortization 0.13 0.055 0.05 0.046 0.037
    Unusual Expense (Income) 0
    Operating Income -3.359 -3.354 -3.239 -1.913 -3.5
    Interest Income (Expense), Net Non-Operating 0.095 0.033 0.026 0.002 0.002
    Gain (Loss) on Sale of Assets 0 0
    Other, Net 0 0 0 0 0
    Net Income Before Taxes -3.264 -3.321 -3.213 -1.911 -3.498
    Net Income After Taxes -3.264 -3.321 -3.215 -1.911 -3.5
    Net Income Before Extra. Items -3.264 -3.321 -3.215 -1.911 -3.5
    Net Income -3.264 -3.321 -3.215 -1.911 -3.5
    Income Available to Common Excl. Extra. Items -3.264 -3.321 -3.215 -1.911 -3.5
    Income Available to Common Incl. Extra. Items -3.264 -3.321 -3.215 -1.911 -3.5
    Diluted Net Income -3.264 -3.321 -3.215 -1.911 -3.5
    Diluted Weighted Average Shares 8.71362 8.71228 8.71097 8.70551 8.7055
    Diluted EPS Excluding Extraordinary Items -0.37459 -0.38119 -0.36907 -0.21952 -0.40204
    Diluted Normalized EPS -0.37459 -0.38119 -0.36907 -0.21952 -0.40204
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 29.533 38.398 28.318 38.574 46.76
    Cash and Short Term Investments 28.675 37.364 27.356 36.477 43.726
    Cash & Equivalents 28.675 37.364 27.356 36.477 43.726
    Total Receivables, Net 0 0.111 0.558 1.028
    Accounts Receivable - Trade, Net 0 0.111 0.503 0.883
    Total Inventory 0 0.49 0.842
    Prepaid Expenses 0.858 1.034 0.851 1.049 1.164
    Total Assets 33.296 39.917 28.441 40.623 49.827
    Property/Plant/Equipment, Total - Net 2.815 0.381 0 1.832 2.788
    Property/Plant/Equipment, Total - Gross 3.886 1.383 0.415 6.413 6.856
    Accumulated Depreciation, Total -1.071 -1.002 -0.415 -4.581 -4.068
    Intangibles, Net 0.094 0.109 0.123 0.137 0.151
    Other Long Term Assets, Total 0.854 1.029 0 0.08 0.128
    Total Current Liabilities 1.383 0.721 1.81 3.737 4.658
    Accounts Payable 0.415 0.281 0.72 0.628 0.464
    Accrued Expenses 0.968 0.44 1.09 2.584 3.526
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0 0.525 0.668
    Total Liabilities 3.087 0.721 1.81 4.325 5.241
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 1.704 0 0.588 0.583
    Total Equity 30.209 39.196 26.631 36.298 44.586
    Common Stock 0.009 0.009 0.131 0.124 0.111
    Additional Paid-In Capital 337.94 335.479 305.965 296.929 278.595
    Retained Earnings (Accumulated Deficit) -307.739 -296.291 -279.465 -260.755 -234.12
    Other Equity, Total 0
    Total Liabilities & Shareholders’ Equity 33.296 39.917 28.441 40.623 49.827
    Total Common Shares Outstanding 8.71063 8.67049 6.52791 6.20077 5.55165
    Treasury Stock - Common -0.001 -0.001
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 29.533 31.171 34.303 36.658 38.398
    Cash and Short Term Investments 28.675 30.269 33.791 36.008 37.364
    Cash & Equivalents 28.675 30.269 33.791 36.008 37.364
    Total Receivables, Net 0
    Accounts Receivable - Trade, Net 0
    Prepaid Expenses 0.858 0.902 0.512 0.65 1.034
    Total Assets 33.296 35.095 35.881 38.294 39.917
    Property/Plant/Equipment, Total - Net 2.815 2.921 0.552 0.554 0.381
    Other Long Term Assets, Total 0.948 1.003 1.026 1.082 1.138
    Total Current Liabilities 1.383 2.006 1.675 0.964 0.721
    Accounts Payable 0.415 0.605 0.958 0.577 0.281
    Accrued Expenses 0.968 1.401 0.717 0.387 0.44
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 3.087 3.802 1.675 0.964 0.721
    Total Long Term Debt 0 0 0 0 0
    Total Equity 30.209 31.293 34.206 37.33 39.196
    Common Stock 0.009 0.009 0.009 0.009 0.009
    Additional Paid-In Capital 337.94 337.113 336.526 336.145 335.479
    Retained Earnings (Accumulated Deficit) -307.739 -305.828 -302.328 -298.823 -296.291
    Treasury Stock - Common -0.001 -0.001 -0.001 -0.001 -0.001
    Total Liabilities & Shareholders’ Equity 33.296 35.095 35.881 38.294 39.917
    Total Common Shares Outstanding 8.71063 8.70555 8.70545 8.69813 8.67049
    Other Liabilities, Total 1.704 1.796
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -11.448 -16.826 -18.71 -26.635 -34.803
    Cash From Operating Activities -8.453 -13.323 -14.882 -20.375 -28.857
    Cash From Operating Activities 0.142 0.041 1.142 0.98 1.267
    Non-Cash Items 2.256 5.575 3.684 5.13 6.767
    Cash Taxes Paid 0.002 -0.002 -0.002 -0.003 0.002
    Changes in Working Capital 0.597 -2.113 -0.998 0.15 -2.088
    Cash From Investing Activities -0.409 -0.393 0.747 -0.076 -0.292
    Capital Expenditures -0.409 -0.405 0 -0.079 -0.296
    Other Investing Cash Flow Items, Total 0 0.012 0.747 0.003 0.004
    Cash From Financing Activities 0.205 23.835 4.935 13.154 10.113
    Issuance (Retirement) of Stock, Net 0.251 23.839 4.996 13.377 10.113
    Issuance (Retirement) of Debt, Net 0
    Foreign Exchange Effects 0 0.011
    Net Change in Cash -8.657 10.119 -9.2 -7.297 -19.025
    Financing Cash Flow Items -0.046 -0.004 -0.061 -0.223
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -9.8 -6.536 -3.215 -11.448 -9.537
    Cash From Operating Activities -7.675 -4.631 -2.414 -8.453 -6.912
    Cash From Operating Activities 0.234 0.104 0.05 0.142 0.096
    Non-Cash Items 1.896 1.346 0.655 2.256 1.429
    Cash Taxes Paid 0.002 0.002 0.002 0.002 0.002
    Changes in Working Capital -0.005 0.455 0.096 0.597 1.1
    Cash From Investing Activities -0.804 -10.779 -10.693 -0.409 -0.356
    Capital Expenditures -0.234 -0.193 -0.074 -0.409 -0.356
    Other Investing Cash Flow Items, Total -0.57 -10.586 -10.619 0 0
    Cash From Financing Activities 0 0 0 0.205 0.205
    Financing Cash Flow Items 0 0 -0.046 -0.046
    Issuance (Retirement) of Stock, Net 0 0 0 0.251 0.251
    Net Change in Cash -8.479 -15.41 -13.107 -8.657 -7.063
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 5.2183 454752 -6624 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.25 283225 151 2022-12-31 LOW
    ARK Investment Management LLC Investment Advisor 2.4591 214302 -60565 2022-12-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.691 147360 -185 2022-12-31 LOW
    Renaissance Technologies LLC Hedge Fund 1.2859 112057 -7830 2022-12-31 HIGH
    Murphy (Keith E) Individual Investor 1.0721 93427 19607 2022-11-10
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7418 64641 -151 2022-12-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.5815 50672 369 2022-12-31 MED
    Cohen (Douglas Jay) Individual Investor 0.3627 31607 19607 2022-11-10 HIGH
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3194 27831 0 2022-12-31 LOW
    Morgan Stanley & Co. LLC Research Firm 0.3111 27113 10 2022-12-31 MED
    Stern (Adam K.) Individual Investor 0.225 19607 19607 2022-11-10 HIGH
    Joshi (Vaidehi) Individual Investor 0.225 19607 19607 2022-11-10
    Milhous (Alison Tjosvold) Individual Investor 0.225 19607 19607 2022-11-10
    Gobel (David) Individual Investor 0.225 19607 19607 2022-11-10 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1659 14461 0 2022-12-31 LOW
    Morgan Stanley Smith Barney LLC Investment Advisor 0.0753 6559 -182 2022-12-31 LOW
    CGM-AZIMUT MONACO Investment Advisor 0.0631 5500 0 2023-01-31 MED
    UBS Financial Services, Inc. Investment Advisor 0.0482 4202 -2041 2022-12-31 LOW
    Advisor Group, Inc Investment Advisor 0.0319 2783 -224 2022-12-31 LOW

    Start a global, multi-asset portfolio with an award-winning platform

    Trade now Desktop

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    Organovo Holdings, Inc. Company profile

    About Organovo Holdings Inc

    Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. NovoGen Bioprinters can dispense pure hydrogel formulations and also serve as important components of company's tissue prototyping and manufacturing platform. The Company also intends to use its bioprinting platform as well as 3D technologies to treat its target diseases.

    Financial summary

    BRIEF: For the nine months ended 31 December 2021, Organovo Holdings Inc revenues was not reported. Net loss decreased 33% to $9.5M. Lower net loss reflects Non-cash stock-based compensation decrease of 78% to $1.2M (expense), Gain (loss) on fixed asset disposals decrease from $19K (expense) to $0K, Other income increase from $6K to $25K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$2.15 to -$1.10.

    Equity composition

    Common Stock $.0001 Par, 06/12 Shares auth.75M and o/s 43,772,483. Insiders 39.83%. 02/12, 10.59135-for-1 Stock split.

    Industry: Biotechnology & Medical Research (NEC)

    Suite 110
    6275 Nancy Ridge Drive
    SAN DIEGO
    CALIFORNIA 92121
    US

    Income Statement

    • Annual
    • Quarterly

    News

    A file photo shows a part of a stack of 500 Canadian gold coins, worth $1 million USD according to Sprott Money, is displayed at the precious metals dealer's booth at the Prospectors and Developers Association of Canada (PDAC) annual conference in Toronto

    PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise

    Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.

    09:37, 31 March 2023
    People use DBS automated teller machines (ATMs) in Singapore March 31, 2022.

    Singapore's DBS has seen inflows in SVB aftermath, CEO says

    DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.

    09:24, 31 March 2023
    Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2023.

    US STOCKS-Futures muted as investors await key inflation data

    U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.

    09:16, 31 March 2023
    A file photo of the logo of Australian energy company Origin pictured in Melbourne, Australia, July 3, 2016

    Asia M&As drop to decade low as tumultuous backdrop deters dealmaking

    Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.

    09:14, 31 March 2023
    A file photo of a worker shoveling coal in a supply truck at a yard on the outskirts of Ahmedabad, India, October 25, 2018.

    Coal India surpasses annual output target for first time in 17 years

    Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.

    09:13, 31 March 2023
    A file photo of bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019.

    Global IPOs marred by banks and recession enjoy few bright spots

    A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.

    09:06, 31 March 2023
    A file photo of Unicredit Bank logo seen in this illustration taken March 12, 2023.

    UniCredit shareholders gather to vote on CEO's new pay scheme

    Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.

    09:04, 31 March 2023

    People also watch

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Long position overnight fee -0.4092%
    Short position overnight fee 0.3873%
    Overnight fee time 21:00 (UTC)
    Spread 0.005

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Long position overnight fee -0.0156%
    Short position overnight fee -0.0063%
    Overnight fee time 21:00 (UTC)
    Spread 0.03

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Long position overnight fee -0.0185%
    Short position overnight fee 0.0102%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Long position overnight fee -0.0249%
    Short position overnight fee 0.0027%
    Overnight fee time 21:00 (UTC)
    Spread 3.0

    Still looking for a broker you can trust?

    Join the 500.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading